Resistance testing: Interpretation and incorporation into HCV treatment algorithms
Jordan J. Feld – 26 May 2017
Jordan J. Feld – 26 May 2017
26 May 2017
Daniel H. Leung – 26 May 2017
26 May 2017
Edward J. Gane – 26 May 2017
Sumeet K. Asrani – 26 May 2017
Alison Darcy, Marianne Samyn – 26 May 2017
Roger W. Chapman – 26 May 2017
Christoph Schramm, John Eaton, Kristina I. Ringe, Sudhakar Venkatesh, Jin Yamamura, for the MRI working group of the IPSCSG – 26 May 2017 – Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra‐ and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information.
Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, Alvaro Santos‐Laso, Ainhoa Lapitz, Maria J. Perugorria, Oihane Erice, Esperanza Gonzalez, Raul Jimenez‐Agüero, Adelaida Lacasta, Cesar Ibarra, Alberto Sanchez‐Campos, Juan P. Jimeno, Frank Lammert, Piotr Milkiewicz, Marco Marzioni, Rocio I.R. Macias, Jose J.G. Marin, Tushar Patel, Gregory J. Gores, Ibon Martinez, Félix Elortza, Juan M. Falcon‐Perez, Luis Bujanda, Jesus M. Banales – 26 May 2017 – Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis.